Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, January 1998, p. 188-189, Vol. 42, No. 1
Department of Medicine,
Received 23 May 1997/Returned for modification 7 August
1997/Accepted 24 October 1997
The in vitro bactericidal interaction of trovafloxacin and rifampin
against Enterococcus spp. has indicated that antagonism occurs between these two antimicrobial agents. This drug combination was examined in vivo in rats with experimental pyelonephritis. The rats
received trovafloxacin, rifampin, or both drugs. On the basis of the
mean log10 CFU of Enterococcus faecalis from
the kidneys, there was no evidence that trovafloxacin and rifampin were
antagonistic in vivo.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Treatment of Enterococcal Pyelonephritis with
Trovafloxacin and Rifampin: In Vitro-In Vivo Contrast
*
Corresponding author. Mailing address: Department of
Medicine, Rancho Los Amigos Medical Center, 7601 East Imperial Highway, Downey, CA 90242. Phone: (562) 401 7461. Fax: (562) 803 6145. E-mail:
Johnmont{at}hsc.usc.edu.
Antimicrobial Agents and Chemotherapy, January 1998, p. 188-189, Vol. 42, No. 1
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |